Tyra Biosciences, Inc. TYRA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $77.39M-15.9% | $91.97M+58.5% | $58.01M-76.9% | $251.21M-16.9% | ||
| $265.45M-23.6% | $347.46M+64.2% | $211.67M-17.7% | $257.29M-15.4% | ||
| $1.31M-20.4% | $1.65M+1.4% | $1.63M+51.2% | $1.08M+4.9% | ||
| $282.61M-22.3% | $363.56M+61.0% | $225.86M-15.1% | $266.18M-13.2% | ||
| $1.18M+99.7% | $590K-87.3% | $4.66M+307% | $1.15M+91.2% | ||
| $18.09M+24.0% | $14.59M-4.8% | $15.33M+169% | $5.7M+57.7% | ||
| $23.43M+14.8% | $20.41M-5.5% | $21.6M+159% | $8.35M+68.3% | ||
| $5K0.0% | $5K+25.0% | $4K0.0% | $4K0.0% | ||
| -$371.26M-47.7% | -$251.31M-52.5% | -$164.83M-72.2% | -$95.7M-137% | ||
| $259.18M-24.5% | $343.15M+68.0% | $204.26M-20.8% | $257.83M-14.6% | ||
| $282.61M-22.3% | $363.56M+61.0% | $225.86M-15.1% | $266.18M-13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Tyra Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 20.49 — current assets exceed current liabilities.
- Where does Tyra Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.